Startup based in the United States, 5 tracked investors.
Vividion Therapeutics is a company founded in 2018 headquartered in the United States. Brouky records 5 investors associated with the company.
Vividion Therapeutics is a biotechnology company that focuses on discovering and developing novel drugs by mapping and targeting previously undruggable proteins in the human genome.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.